Clinical Trials

Hepatic Impairment

NCT05035667 2026-04-16

Patient Considerations of Social Media Account Management After Death

Active not recruiting

117 enrolled

Advanced Malignant Solid Neoplasm

NCT05642611 2026-04-16

ICE COMPRESS

Phase 3 Recruiting

777 enrolled

Malignant Solid Neoplasm

NCT06066424 2026-04-16

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

54 enrolled

Phase 1 Active not recruiting

Solid Tumors

NCT06082960 2026-04-16

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

45 enrolled

Solid Tumors

NCT06126276 2026-04-16

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Phase 2 Recruiting

70 enrolled

Malignant Female Reproductive System Neoplasm

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

128 enrolled

Solid Tumor

NCT06598371 2026-04-16

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

141 enrolled

Select Advanced Solid Tumors

NCT06625593 2026-04-16

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

168 enrolled

Advanced Solid Tumor

NCT07205718 2026-04-16

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

223 enrolled

Advanced or Metastatic Solid Tumors

NCT07266428 2026-04-16

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

170 enrolled

Phase NA Not yet recruiting

Advanced Solid Tumors

NCT07278739 2026-04-16

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

1,020 enrolled

Malignant Solid Neoplasm

NCT07380334 2026-04-16

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

200 enrolled

Phase 1 Not yet recruiting

Advanced Solid Tumor

NCT07533708 2026-04-16

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

48 enrolled

Phase NA Not yet recruiting

mCRPC or Advanced/Metastatic Solid Tumors

NCT07534813 2026-04-16

A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors

16 enrolled

Advanced Solid Tumors

NCT03736889 2026-04-15

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

Phase 2 Recruiting

200 enrolled

MSI-H/dMMR Solid Tumors

NCT04219254 2026-04-15

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

197 enrolled

Solid Tumor, Adult

NCT04886271 2026-04-15

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

Phase 2 Completed

20 enrolled

CNSGastrointestinalOther solid neoplasmSarcomaThoracic

Advanced Solid Tumor

NCT05275478 2026-04-15

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Phase 1/2 Terminated

110 enrolled

Glioblastoma, Mesothelioma, Sarcoma, Cholangiocarcinoma, Neurofibrosarcoma

NCT05718895 2026-04-15

CLINCH

156 enrolled

Advanced/Metastatic Solid Tumors

NCT06233942 2026-04-15

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

308 enrolled

Advanced Solid Tumor

NCT06596473 2026-04-15

A Study of BG-C477 in Participants With Advanced Solid Tumors

310 enrolled

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

Advanced Solid Tumors

NCT06638931 2026-04-15

ANTARES

Phase 2 Recruiting

28 enrolled

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

660 enrolled

Advanced Solid Tumors

NCT07181681 2026-04-15

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

63 enrolled

Solid Tumors

NCT07226349 2026-04-15

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

105 enrolled

Advanced Solid Tumor

NCT07362888 2026-04-15

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

180 enrolled

Solid Tumors (Phase 1)

NCT07395258 2026-04-15

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

60 enrolled

Solid Tumors

NCT07530458 2026-04-15

Retinoblastoma Consolidation in Egyptians

Not yet recruiting

150 enrolled

CNSGenitourinaryOther solid neoplasmSarcoma

Retinoblastoma

NCT01109394 2026-04-14

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Recruiting

6,035 enrolled

Kidney Neoplasms, Neoplasms, Neuroblastoma, Retinoblastoma, Sarcoma

NCT03016156 2026-04-14

Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

Phase NA Terminated

1 enrolled

Hydrophthalmos, Retinoblastoma

NCT03447483 2026-04-14

MOTIVATE

Phase NA Completed

150 enrolled

Solid Tumor

NCT04142437 2026-04-14

ON-TRK

Recruiting

150 enrolled